NG_008035.1:g.19394T>A NC_000001.11:g.53210822T>A NC_000001.10:g.53676494T>A NP_000089.1:p.Phe383Tyr
NM_000098.3:c.1148T>A NP_000089.1:p.Phe282Tyr P23786:p.Phe383Tyr NM_001330589.2:c.1148T>A NM_000098.2:c.1148T>A NP_001317518.1:p.Phe383Tyr c.1148T>A (p.Phe383Tyr) More...
|
10/31/2018 |
missense|missense variant |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
all ages|variable |
<1 / 1 000 000 |
Abnormality of the nervous system; Carnitine palmitoyl transferase 2 deficiency; Carnitine palmitoyl transferase II deficiency, myopathic form; Carnitine palmitoyl transferase II deficiency, neonatal form; Carnitine palmitoyltransferase deficiency type 2; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY WITH HYPOKETOTIC HYPOGLYCEMIA; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ADULT-ONSET; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, HEPATOCARDIOMUSCULAR; Carnitine palmitoyltransferase II deficiency, infantile; Carnitine palmitoyltransferase II deficiency, late-onset; Carnitine palmitoyltransferase II deficiency, lethal neonatal; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC; Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced; CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL; Congenital nervous system disorder; CPT II DEFICIENCY, HEPATIC; CPT II deficiency, infantile; CPT II DEFICIENCY, LETHAL NEONATAL; CPT II DEFICIENCY, MYOPATHIC; CPT II deficiency, myopathic, stress-induced; CPT2 DEFICIENCY, INFANTILE; CPT2 DEFICIENCY, LATE-ONSET; CPT2 DEFICIENCY, LETHAL NEONATAL; Encephalopathy, acute, infection-induced, susceptibility to, 4; Seizures |